The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Arbidol Hydrochloride (COVID-19) Market Research Report 2025
Synopsis
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
The global Arbidol Hydrochloride (COVID-19) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Arbidol Hydrochloride (COVID-19) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Arbidol Hydrochloride (COVID-19) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Arbidol Hydrochloride (COVID-19) include JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical, Simcere Pharmaceutical and Jiangsu Lianshui Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Arbidol Hydrochloride (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arbidol Hydrochloride (COVID-19).
Report Scope
The Arbidol Hydrochloride (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Arbidol Hydrochloride (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arbidol Hydrochloride (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
Jiangsu Lianshui Pharmaceutical
Segment by Type
Arbidol Hydrochloride Tablets
Arbidol Hydrochloride Capsules
Arbidol Hydrochloride Granules
Segment by Application
Anti Influenza Virus
COVID-19
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Arbidol Hydrochloride (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Arbidol Hydrochloride (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Arbidol Hydrochloride as known as Arbidol, is an antiviral treatment for influenza infection.
The global Arbidol Hydrochloride (COVID-19) market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Arbidol Hydrochloride (COVID-19) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Arbidol Hydrochloride (COVID-19) is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Arbidol Hydrochloride (COVID-19) include JSC Pharmstandard, Jiangsu Wuzhong Pharmaceutical, CSPC Ouyi Pharmaceutical, Simcere Pharmaceutical and Jiangsu Lianshui Pharmaceutical, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Arbidol Hydrochloride (COVID-19), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Arbidol Hydrochloride (COVID-19).
Report Scope
The Arbidol Hydrochloride (COVID-19) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Arbidol Hydrochloride (COVID-19) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Arbidol Hydrochloride (COVID-19) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
JSC Pharmstandard
Jiangsu Wuzhong Pharmaceutical
CSPC Ouyi Pharmaceutical
Simcere Pharmaceutical
Jiangsu Lianshui Pharmaceutical
Segment by Type
Arbidol Hydrochloride Tablets
Arbidol Hydrochloride Capsules
Arbidol Hydrochloride Granules
Segment by Application
Anti Influenza Virus
COVID-19
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Arbidol Hydrochloride (COVID-19) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Arbidol Hydrochloride (COVID-19) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Arbidol Hydrochloride (COVID-19) Market Overview
1.1 Product Overview and Scope of Arbidol Hydrochloride (COVID-19)
1.2 Arbidol Hydrochloride (COVID-19) Segment by Type
1.2.1 Global Arbidol Hydrochloride (COVID-19) Market Value Comparison by Type (2024-2030)
1.2.2 Arbidol Hydrochloride Tablets
1.2.3 Arbidol Hydrochloride Capsules
1.2.4 Arbidol Hydrochloride Granules
1.3 Arbidol Hydrochloride (COVID-19) Segment by Application
1.3.1 Global Arbidol Hydrochloride (COVID-19) Market Value by Application: (2024-2030)
1.3.2 Anti Influenza Virus
1.3.3 COVID-19
1.4 Global Arbidol Hydrochloride (COVID-19) Market Size Estimates and Forecasts
1.4.1 Global Arbidol Hydrochloride (COVID-19) Revenue 2019-2030
1.4.2 Global Arbidol Hydrochloride (COVID-19) Sales 2019-2030
1.4.3 Global Arbidol Hydrochloride (COVID-19) Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Arbidol Hydrochloride (COVID-19) Market Competition by Manufacturers
2.1 Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Manufacturers (2019-2024)
2.2 Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Arbidol Hydrochloride (COVID-19) Average Price by Manufacturers (2019-2024)
2.4 Global Arbidol Hydrochloride (COVID-19) Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Arbidol Hydrochloride (COVID-19), Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Arbidol Hydrochloride (COVID-19), Product Type & Application
2.7 Arbidol Hydrochloride (COVID-19) Market Competitive Situation and Trends
2.7.1 Arbidol Hydrochloride (COVID-19) Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Arbidol Hydrochloride (COVID-19) Players Market Share by Revenue
2.7.3 Global Arbidol Hydrochloride (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Arbidol Hydrochloride (COVID-19) Retrospective Market Scenario by Region
3.1 Global Arbidol Hydrochloride (COVID-19) Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Arbidol Hydrochloride (COVID-19) Global Arbidol Hydrochloride (COVID-19) Sales by Region: 2019-2030
3.2.1 Global Arbidol Hydrochloride (COVID-19) Sales by Region: 2019-2024
3.2.2 Global Arbidol Hydrochloride (COVID-19) Sales by Region: 2025-2030
3.3 Global Arbidol Hydrochloride (COVID-19) Global Arbidol Hydrochloride (COVID-19) Revenue by Region: 2019-2030
3.3.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Region: 2019-2024
3.3.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Region: 2025-2030
3.4 North America Arbidol Hydrochloride (COVID-19) Market Facts & Figures by Country
3.4.1 North America Arbidol Hydrochloride (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2030)
3.4.3 North America Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Arbidol Hydrochloride (COVID-19) Market Facts & Figures by Country
3.5.1 Europe Arbidol Hydrochloride (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2030)
3.5.3 Europe Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Arbidol Hydrochloride (COVID-19) Market Facts & Figures by Country
3.6.1 Asia Pacific Arbidol Hydrochloride (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2030)
3.6.3 Asia Pacific Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Arbidol Hydrochloride (COVID-19) Market Facts & Figures by Country
3.7.1 Latin America Arbidol Hydrochloride (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2030)
3.7.3 Latin America Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Facts & Figures by Country
3.8.1 Middle East and Africa Arbidol Hydrochloride (COVID-19) Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2030)
3.8.3 Middle East and Africa Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Arbidol Hydrochloride (COVID-19) Sales by Type (2019-2030)
4.1.1 Global Arbidol Hydrochloride (COVID-19) Sales by Type (2019-2024)
4.1.2 Global Arbidol Hydrochloride (COVID-19) Sales by Type (2025-2030)
4.1.3 Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2019-2030)
4.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2019-2030)
4.2.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2019-2024)
4.2.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Type (2025-2030)
4.2.3 Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2019-2030)
4.3 Global Arbidol Hydrochloride (COVID-19) Price by Type (2019-2030)
5 Segment by Application
5.1 Global Arbidol Hydrochloride (COVID-19) Sales by Application (2019-2030)
5.1.1 Global Arbidol Hydrochloride (COVID-19) Sales by Application (2019-2024)
5.1.2 Global Arbidol Hydrochloride (COVID-19) Sales by Application (2025-2030)
5.1.3 Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2019-2030)
5.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2019-2030)
5.2.1 Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2019-2024)
5.2.2 Global Arbidol Hydrochloride (COVID-19) Revenue by Application (2025-2030)
5.2.3 Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2019-2030)
5.3 Global Arbidol Hydrochloride (COVID-19) Price by Application (2019-2030)
6 Key Companies Profiled
6.1 JSC Pharmstandard
6.1.1 JSC Pharmstandard Corporation Information
6.1.2 JSC Pharmstandard Description and Business Overview
6.1.3 JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.1.4 JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Product Portfolio
6.1.5 JSC Pharmstandard Recent Developments/Updates
6.2 Jiangsu Wuzhong Pharmaceutical
6.2.1 Jiangsu Wuzhong Pharmaceutical Corporation Information
6.2.2 Jiangsu Wuzhong Pharmaceutical Description and Business Overview
6.2.3 Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
6.2.5 Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
6.3 CSPC Ouyi Pharmaceutical
6.3.1 CSPC Ouyi Pharmaceutical Corporation Information
6.3.2 CSPC Ouyi Pharmaceutical Description and Business Overview
6.3.3 CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
6.3.5 CSPC Ouyi Pharmaceutical Recent Developments/Updates
6.4 Simcere Pharmaceutical
6.4.1 Simcere Pharmaceutical Corporation Information
6.4.2 Simcere Pharmaceutical Description and Business Overview
6.4.3 Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
6.4.5 Simcere Pharmaceutical Recent Developments/Updates
6.5 Jiangsu Lianshui Pharmaceutical
6.5.1 Jiangsu Lianshui Pharmaceutical Corporation Information
6.5.2 Jiangsu Lianshui Pharmaceutical Description and Business Overview
6.5.3 Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Product Portfolio
6.5.5 Jiangsu Lianshui Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Arbidol Hydrochloride (COVID-19) Industry Chain Analysis
7.2 Arbidol Hydrochloride (COVID-19) Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Arbidol Hydrochloride (COVID-19) Production Mode & Process
7.4 Arbidol Hydrochloride (COVID-19) Sales and Marketing
7.4.1 Arbidol Hydrochloride (COVID-19) Sales Channels
7.4.2 Arbidol Hydrochloride (COVID-19) Distributors
7.5 Arbidol Hydrochloride (COVID-19) Customers
8 Arbidol Hydrochloride (COVID-19) Market Dynamics
8.1 Arbidol Hydrochloride (COVID-19) Industry Trends
8.2 Arbidol Hydrochloride (COVID-19) Market Drivers
8.3 Arbidol Hydrochloride (COVID-19) Market Challenges
8.4 Arbidol Hydrochloride (COVID-19) Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Arbidol Hydrochloride (COVID-19) Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Arbidol Hydrochloride (COVID-19) Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Arbidol Hydrochloride (COVID-19) Market Competitive Situation by Manufacturers in 2023
Table 4. Global Arbidol Hydrochloride (COVID-19) Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Arbidol Hydrochloride (COVID-19) Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Arbidol Hydrochloride (COVID-19) Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Arbidol Hydrochloride (COVID-19) Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Arbidol Hydrochloride (COVID-19), Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Arbidol Hydrochloride (COVID-19), Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Arbidol Hydrochloride (COVID-19), Product Type & Application
Table 12. Global Key Manufacturers of Arbidol Hydrochloride (COVID-19), Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Arbidol Hydrochloride (COVID-19) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Arbidol Hydrochloride (COVID-19) as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Arbidol Hydrochloride (COVID-19) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2019-2024) & (K Units)
Table 18. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Region (2019-2024)
Table 19. Global Arbidol Hydrochloride (COVID-19) Sales by Region (2025-2030) & (K Units)
Table 20. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Region (2025-2030)
Table 21. Global Arbidol Hydrochloride (COVID-19) Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region (2019-2024)
Table 23. Global Arbidol Hydrochloride (COVID-19) Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region (2025-2030)
Table 25. North America Arbidol Hydrochloride (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2024) & (K Units)
Table 27. North America Arbidol Hydrochloride (COVID-19) Sales by Country (2025-2030) & (K Units)
Table 28. North America Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Arbidol Hydrochloride (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Arbidol Hydrochloride (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2024) & (K Units)
Table 32. Europe Arbidol Hydrochloride (COVID-19) Sales by Country (2025-2030) & (K Units)
Table 33. Europe Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Arbidol Hydrochloride (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Arbidol Hydrochloride (COVID-19) Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Arbidol Hydrochloride (COVID-19) Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Arbidol Hydrochloride (COVID-19) Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Arbidol Hydrochloride (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Arbidol Hydrochloride (COVID-19) Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Arbidol Hydrochloride (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Arbidol Hydrochloride (COVID-19) Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Arbidol Hydrochloride (COVID-19) Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Arbidol Hydrochloride (COVID-19) Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Arbidol Hydrochloride (COVID-19) Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Arbidol Hydrochloride (COVID-19) Sales (K Units) by Type (2019-2024)
Table 51. Global Arbidol Hydrochloride (COVID-19) Sales (K Units) by Type (2025-2030)
Table 52. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2019-2024)
Table 53. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Type (2025-2030)
Table 54. Global Arbidol Hydrochloride (COVID-19) Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Arbidol Hydrochloride (COVID-19) Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2019-2024)
Table 57. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Type (2025-2030)
Table 58. Global Arbidol Hydrochloride (COVID-19) Price (US$/Unit) by Type (2019-2024)
Table 59. Global Arbidol Hydrochloride (COVID-19) Price (US$/Unit) by Type (2025-2030)
Table 60. Global Arbidol Hydrochloride (COVID-19) Sales (K Units) by Application (2019-2024)
Table 61. Global Arbidol Hydrochloride (COVID-19) Sales (K Units) by Application (2025-2030)
Table 62. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2019-2024)
Table 63. Global Arbidol Hydrochloride (COVID-19) Sales Market Share by Application (2025-2030)
Table 64. Global Arbidol Hydrochloride (COVID-19) Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Arbidol Hydrochloride (COVID-19) Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2019-2024)
Table 67. Global Arbidol Hydrochloride (COVID-19) Revenue Market Share by Application (2025-2030)
Table 68. Global Arbidol Hydrochloride (COVID-19) Price (US$/Unit) by Application (2019-2024)
Table 69. Global Arbidol Hydrochloride (COVID-19) Price (US$/Unit) by Application (2025-2030)
Table 70. JSC Pharmstandard Corporation Information
Table 71. JSC Pharmstandard Description and Business Overview
Table 72. JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. JSC Pharmstandard Arbidol Hydrochloride (COVID-19) Product
Table 74. JSC Pharmstandard Recent Developments/Updates
Table 75. Jiangsu Wuzhong Pharmaceutical Corporation Information
Table 76. Jiangsu Wuzhong Pharmaceutical Description and Business Overview
Table 77. Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Jiangsu Wuzhong Pharmaceutical Arbidol Hydrochloride (COVID-19) Product
Table 79. Jiangsu Wuzhong Pharmaceutical Recent Developments/Updates
Table 80. CSPC Ouyi Pharmaceutical Corporation Information
Table 81. CSPC Ouyi Pharmaceutical Description and Business Overview
Table 82. CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CSPC Ouyi Pharmaceutical Arbidol Hydrochloride (COVID-19) Product
Table 84. CSPC Ouyi Pharmaceutical Recent Developments/Updates
Table 85. Simcere Pharmaceutical Corporation Information
Table 86. Simcere Pharmaceutical Description and Business Overview
Table 87. Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Simcere Pharmaceutical Arbidol Hydrochloride (COVID-19) Product
Table 89. Simcere Pharmaceutical Recent Developments/Updates
Table 90. Jiangsu Lianshui Pharmaceutical Corporation Information
Table 91. Jiangsu Lianshui Pharmaceutical Description and Business Overview
Table 92. Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Jiangsu Lianshui Pharmaceutical Arbidol Hydrochloride (COVID-19) Product
Table 94. Jiangsu Lianshui Pharmaceutical Recent Developments/Updates
Table 95. Key Raw Materials Lists
Table 96. Raw Materials Key Suppliers Lists
Table 97. Arbidol Hydrochloride (COVID-19) Distributors List
Table 98. Arbidol Hydrochloride (COVID-19) Customers List
Table 99. Arbidol Hydrochloride (COVID-19) Market Trends
Table 100. Arbidol Hydrochloride (COVID-19) Market Drivers
Table 101. Arbidol Hydrochloride (COVID-19) Market Challenges
Table 102. Arbidol Hydrochloride (COVID-19) Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Arbidol Hydrochloride (COVID-19)
Figure 2. Global Arbidol Hydrochloride (COVID-19) Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Arbidol Hydrochloride (COVID-19) Market Share by Type in 2023 & 2030
Figure 4. Arbidol Hydrochloride Tablets Product Picture
Figure 5. Arbidol Hydrochloride Capsules Product Picture
Figure 6. Arbidol Hydrochloride Granules Product Picture
Figure 7. Global Arbidol Hydrochloride (COVID-19) Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Arbidol Hydrochloride (COVID-19) Market Share by Application in 2023 & 2030
Figure 9. Anti Influenza Virus
Figure 10. COVID-19
Figure 11. Global Arbidol Hydrochloride (COVID-19) Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Arbidol Hydrochloride (COVID-19) Market Size (2019-2030) & (US$ Million)
Figure 13. Global Arbidol Hydrochloride (COVID-19) Sales (2019-2030) & (K Units)
Figure 14. Global Arbidol Hydrochloride (COVID-19) Average Price (US$/Unit) & (2019-2030)
Figure 15. Arbidol Hydrochloride (COVID-19) Report Years Considered
Figure 16. Arbidol Hydrochloride (COVID-19) Sales Share by Manufacturers in 2023
Figure 17. Global Arbidol Hydrochloride (COVID-19) Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Arbidol Hydrochloride (COVID-19) Players: Market Share by Revenue in 2023
Figure 19. Arbidol Hydrochloride (COVID-19) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Arbidol Hydrochloride (COVID-19) Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2019-2030)
Figure 22. North America Arbidol Hydrochloride (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 23. United States Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2019-2030)
Figure 26. Europe Arbidol Hydrochloride (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 27. Germany Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Arbidol Hydrochloride (COVID-19) Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Arbidol Hydrochloride (COVID-19) Revenue Market Share by Region (2019-2030)
Figure 34. China Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2019-2030)
Figure 44. Latin America Arbidol Hydrochloride (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Arbidol Hydrochloride (COVID-19) Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Arbidol Hydrochloride (COVID-19) Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Arbidol Hydrochloride (COVID-19) Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Arbidol Hydrochloride (COVID-19) by Type (2019-2030)
Figure 54. Global Revenue Market Share of Arbidol Hydrochloride (COVID-19) by Type (2019-2030)
Figure 55. Global Arbidol Hydrochloride (COVID-19) Price (US$/Unit) by Type (2019-2030)
Figure 56. Global Sales Market Share of Arbidol Hydrochloride (COVID-19) by Application (2019-2030)
Figure 57. Global Revenue Market Share of Arbidol Hydrochloride (COVID-19) by Application (2019-2030)
Figure 58. Global Arbidol Hydrochloride (COVID-19) Price (US$/Unit) by Application (2019-2030)
Figure 59. Arbidol Hydrochloride (COVID-19) Value Chain
Figure 60. Arbidol Hydrochloride (COVID-19) Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
